[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346534-105":59,"doc-detail-346534-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","current-research-progress-on-abhd5-in-cancers","Current Research Progress on ABHD5 in Cancers","","Lipid metabolism underpins tumor initiation, progression, metastasis, and chemoresistance, making lipid-flux regulation a key vulnerability for anticancer strategies. This review focuses on ABHD5, a regulator of lipid droplet mobilization with context-dependent effects across cancers. Drawing on experimental and clinical findings, it links ABHD5 to signaling networks including AMPK/mTOR, AKT, and NF-κB and explains why ABHD5 can suppress or promote tumor growth. The article also evaluates its potential as a diagnostic marker and therapeutic target, emphasizing precision rather than blanket intervention.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/current-research-progress-on-abhd5-in-cancers/346534/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/current-research-progress-on-abhd5-in-cancers/346534.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What roles does ABHD5 play in lipid metabolism and cancer?","Question",{"text":112,"@type":113},"ABHD5 is a key regulator of lipid droplet mobilization and lipid metabolic control. In cancer, it shows context-dependent behavior, acting as a tumor suppressor in many solid tumors but promoting progression in specific settings such as endometrial cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does ABHD5 connect to major signaling pathways?",{"text":117,"@type":113},"ABHD5 intersects with signaling pathways including AMPK/mTOR, AKT, and NF-κB. Through these connections, it influences proliferation, invasion, apoptosis, immune evasion, and drug responsiveness.",{"name":119,"@type":110,"acceptedAnswer":120},"Why does ABHD5 have contradictory effects across different cancer types?",{"text":121,"@type":113},"The review attributes the contradictions to biological and molecular context, where ABHD5 can shift the balance between tumor-suppressive and oncogenic outcomes. Colorectal and prostate cancers are highlighted as having an especially ambiguous middle ground.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346534,1791263689,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Review  \nCurrent Research Progress on ABHD5 in Cancers  \nHuazhong Cai 1,2, *,†, Hao Chen 1,2,†, Jiexing Ye 3, Zhesi Jin 1,2 and Pan Huang 1,2, *  \nAcademic Editor: Bulent Ozpolat  \nReceived: 20 December 2025  \nRevised: 28 January 2026  \nAccepted: 2 February 2026  \nPublished: 10 February 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Emergency, Affiliated Hospital of Jiangsu University, Zhenjiang 212000, China; [chenh723@163.com](chenh723@163.com) (H.C.); [jinzhesi@126.com](jinzhesi@126.com) (Z.J.)  \n2 School of Medicine, Jiangsu University, Zhenjiang 212000, China  \n3 School of Public Health, Anhui Mediecal University, Hefei 230000, China; [13655590443@163.com](13655590443@163.com)  \n* Correspondence: [caihz021@ujs.edu.cn](caihz021@ujs.edu.cn) (H.C.); [phuang@ujs.edu.cn](phuang@ujs.edu.cn) (P.H.)† These authors contributed equally to this work.  \nSimple Summary  \nABHD5 is a key regulator of lipid metabolism, with context-dependent roles in cancer. It interacts with signaling pathways like AMPK/mTOR, AKT, and NF-κB, exerting either tumor-suppressive or oncogenic effects based on the tumor’s ecological and molecular context. This review synthesizes experimental and clinical evidence to clarify its multifaceted functions and explores its potential as a diagnostic marker and therapeutic target, emphasizing the need for precision strategies rather than blunt intervention.  \nAbstract  \nLipid metabolism sits at the heart of tumor initiation, progression, metastasis, and resistance to chemotherapy. Against this background, the regulation of lipid flux has emerged as a fertile ground for anticancer strategies. Chanarin–Dorfman syndrome (CDS), a rare genetic disorder marked by massive lipid droplet accumulation, offers compelling human evidence that α/β-hydrolase domain-containing protein 5 (ABHD5) plays a central role in lipid droplet mobilization through the ATGL axis. This clinical insight has, perhaps unexpectedly, pushed ABHD5 into the spotlight of cancer research. ABHD5 does not behave uniformly across malignancies. In many solid tumors—such as lung, liver, and renal cell carcinoma—it restrains tumor growth. Yet in other settings, notably endometrial cancer, it appears to fuel malignant progression. Colorectal and prostate cancers occupy amore ambiguous middle ground, where ABHD5 can tip the balance in either direction depending on context. Mechanistically, ABHD5 influences lipid homeostasis and cell fate by intersecting with signaling pathways including AMPK/mTOR, AKT, and NF-κB, thereby shaping proliferation, invasion, apoptosis, immune evasion, and drug responsiveness. This review brings together experimental and clinical evidence to map the diverse, sometimes contradictory roles of ABHD5 in cancer. By tracing its context-dependent functions and molecular circuits, we also explore its emerging value as a diagnostic marker and a therapeutic target—one that demands nuance rather than blunt intervention.  \nKeywords: ABHD5; lipid metabolism; cancer; pathway  \n1. Introduction  \nCellular physiology is critically dependent on precise lipid metabolic regulation, which governs core biological activities. Abnormalities in this metabolic process have been demonstrated to be closely associated with the occurrence and development of tumors [1] . The α/β hydrolase domain (ABHD) family has emerged as a key regulator in lipid metabolism  \nand tumor biology, attracting extensive research interest due to its pivotal functional roles [2] . Among the ABHD family members, ABHD5, also known as comparative gene identification-58 (CGI-58), stands out for its multifaceted and context-dependent roles in oncology, warranting a focused review [3,4] . The expression and activity of ABHD5 are subject to regulation by various factors, including nutritional status, hormone levels,","cbCaibbX2pvHlEPV","https://ap.wps.com/l/cbCaibbX2pvHlEPV","pdf",1185546,15,"English","# Introduction\n## ABHD5 as a regulator of lipid metabolism and cancer\n## Clinical and genetic evidence (CDS and lipid droplet mobilization)\n## Context-dependent dual roles of ABHD5 in malignancies\n# Mechanistic links and signaling pathways\n## AMPK/mTOR, AKT, and NF-κB signaling\n## Effects on proliferation, invasion, apoptosis, and immune evasion\n## Drug responsiveness and treatment implications\n# Translational potential\n## Diagnostic marker value\n## Therapeutic targeting and precision strategies","[{\"question\":\"What roles does ABHD5 play in lipid metabolism and cancer?\",\"answer\":\"ABHD5 is a key regulator of lipid droplet mobilization and lipid metabolic control. In cancer, it shows context-dependent behavior, acting as a tumor suppressor in many solid tumors but promoting progression in specific settings such as endometrial cancer.\"},{\"question\":\"How does ABHD5 connect to major signaling pathways?\",\"answer\":\"ABHD5 intersects with signaling pathways including AMPK/mTOR, AKT, and NF-κB. Through these connections, it influences proliferation, invasion, apoptosis, immune evasion, and drug responsiveness.\"},{\"question\":\"Why does ABHD5 have contradictory effects across different cancer types?\",\"answer\":\"The review attributes the contradictions to biological and molecular context, where ABHD5 can shift the balance between tumor-suppressive and oncogenic outcomes. Colorectal and prostate cancers are highlighted as having an especially ambiguous middle ground.\"}]","Current Research Progress on ABHD5 in Cancers | PDF",1790061871,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5660da25916d582dc05d54e234098057.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/145111db28b94fafeeaa153f978dd1b3.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3800e78670f6555d9eca0c9f559fc15.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6fc2c4d82daf5b610480c2f6abaa3ee6.webp",980,1385]